Latest Strategic Investment News

Eastern Metals has agreed to sell its Browns Reef Project tenements to Australian Gold and Copper, offering shareholders an immediate benefit and ongoing exposure through share distribution.

Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.

Unibail-Rodamco-Westfield N.V. reports a positive net income for the first half of 2025, driven by robust US shopping center performance and strategic investments. The company also advances its ESG commitments and plans to delist from the ASX by August.

Patronus Resources (ASX – PTN) reveals a robust financial position with $81 million in cash and investments against a $106 million market cap, underpinned by 2.3 million ounces of gold equivalent resources across Western Australia and Northern Territory.

Galan Lithium has formalised a $20 million strategic investment agreement with The Clean Elements Fund to fund the initial phase of its Hombre Muerto West lithium project in Argentina, aiming for production in early 2026.

Pure Foods Tasmania reports solid progress in its turnaround strategy with significant cost reductions and improved product quality, setting the stage for profitable growth in FY26.

8common Limited has closed FY25 with a positive operational cash flow and EBITDA, driven by record SaaS revenue and significant margin improvements following major infrastructure upgrades.

African Gold Ltd has reported a remarkable 119% increase in its Blaffo Guetto inferred gold resource to nearly 1 million ounces, underpinning a fully funded 40,000m drilling program at its Didievi Project in Côte d’Ivoire.

X2M Connect reports improved revenue trends and a strengthened balance sheet after securing $5.5 million in new contracts, positioning the company for growth in FY26. A recent capital raise aims to reduce debt and fund expansion in key markets.

FortifAI Limited reports steady revenue, significant cost reductions, and a strengthened balance sheet with $3 million cash and no debt. The company advances its AI Lab initiative while expanding its project pipeline and board expertise.

4DMedical has landed a $10 million strategic investment from Pro Medicus, aimed at accelerating its commercial growth and advancing its CT – VQ™ technology towards FDA clearance in the US.

4DMedical reports a 56% revenue surge in FY25 alongside a strategic $10 million investment from Pro Medicus, advancing its CT, VQ™ lung imaging technology towards FDA clearance.